Epidemiology of hepatitis C virus infection.

Globally, hepatitis C virus (HCV) has infected an estimated 130 million people, most of whom are chronically infected. HCV-infected people serve as a reservoir for transmission to others and are at risk for developing chronic liver disease, cirrhosis, and primary hepatocellular carcinoma (HCC). It has been estimated that HCV accounts for 27% of cirrhosis and 25% of HCC worldwide. HCV infection has likely been endemic in many populations for centuries. However, the wave of increased HCV-related morbidity and mortality that we are now facing is the result of an unprecedented increase in the spread of HCV during the 20th century. Two 20th century events appear to be responsible for this increase; the widespread availability of injectable therapies and the illicit use of injectable drugs.

[1]  M. Kohara,et al.  Incident hepatitis C virus infection in a community‐based population in Japan , 2002, Journal of viral hepatitis.

[2]  J. Kaldor,et al.  Surveillance for newly acquired hepatitis C in Australia , 2004, Journal of gastroenterology and hepatology.

[3]  M. Favero,et al.  SURVIVAL OF HEPATITIS B VIRUS AFTER DRYING AND STORAGE FOR ONE WEEK , 1981, The Lancet.

[4]  Inda,et al.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.

[5]  E. Roberts,et al.  Maternal‐infant transmission of hepatitis C virus infection , 2002, Hepatology.

[6]  R. Tedder,et al.  Comparison of commercial assays for the quantification of HBV DNA load in health care workers: calibration differences. , 2002, Journal of virological methods.

[7]  H. Thio,et al.  A cluster of acute hepatitis C virus infection among men who have sex with men – results from contact tracing and public health implications , 2005, AIDS.

[8]  A. Valleron,et al.  Modeling the hepatitis C virus epidemic in france , 1999, Hepatology.

[9]  B. Bell,et al.  Viral hepatitis transmission in ambulatory health care settings. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  A. Craxì,et al.  Endemic hepatitis C virus infection in a Sicilian town: Further evidence for iatrogenic transmission , 2002, Journal of medical virology.

[11]  M. Alter,et al.  Prevalence and screening costs of hepatitis C virus among Ugandan blood donors , 2006, Tropical medicine & international health : TM & IH.

[12]  Á. Domínguez,et al.  Community‐based seroepidemiological survey of HCV infection in Catalonia, Spain , 2001, Journal of medical virology.

[13]  M. Alter,et al.  Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population. , 1982, The Journal of infectious diseases.

[14]  M. Alter Epidemiology of hepatitis C. , 1996, European journal of gastroenterology & hepatology.

[15]  Matthew G Law,et al.  The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users. , 2003, International journal of epidemiology.

[16]  L. Magder,et al.  The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt , 2000, The Lancet.

[17]  E. Sagnelli,et al.  The importance of HCV on the burden of chronic liver disease in Italy: A multicenter prevalence study of 9,997 cases , 2005, Journal of medical virology.

[18]  M. Alter,et al.  The coming wave of HCV-related liver disease: dilemmas and challenges. , 2006, Journal of hepatology.

[19]  J. Fraumeni,et al.  Hepatitis C Virus Infection, , 2022 .

[20]  L. Magder,et al.  Intrafamilial transmission of hepatitis C in Egypt , 2005, Hepatology.

[21]  Y. Gilleece,et al.  Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase? , 2004, Sexually Transmitted Infections.

[22]  Y. Hutin,et al.  The global burden of disease attributable to contaminated injections given in health care settings , 2004, International journal of STD & AIDS.

[23]  J. Kaldor,et al.  Epidemiology of hepatitis C virus infection in Australia. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[24]  F. Carrat,et al.  Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. , 2006, Journal of hepatology.

[25]  R. Corona,et al.  Heterosexual transmission of hepatitis C in Italy , 1999, Journal of medical virology.

[26]  M. Alter,et al.  The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.

[27]  M. Alter,et al.  Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. , 2005, The Journal of infectious diseases.

[28]  A. Zanella,et al.  The incidence and risk factors of community‐acquired hepatitis C in a cohort of Italian blood donors , 1997, Hepatology.

[29]  P. Couzigou,et al.  Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study , 2005, Journal of viral hepatitis.

[30]  M. Alter,et al.  Epidemiology of Hepatitis C , 2018, Clinical liver disease.

[31]  R. Garfein,et al.  Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. , 2002, American journal of epidemiology.

[32]  S. Glynn,et al.  A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors , 2005, Transfusion.

[33]  M. Alter,et al.  Infectivity of Hepatitis C Virus in Plasma After Drying and Storing at Room Temperature , 2007, Infection Control & Hospital Epidemiology.

[34]  M. Alter,et al.  Prevention of spread of hepatitis C , 2002, Hepatology.

[35]  L. Finelli,et al.  Epidemiology of Hepatitis B and Hepatitis B Virus Infection in United States Children , 2005, The Pediatric infectious disease journal.

[36]  H. Margolis,et al.  Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. , 1989, JAMA.

[37]  J. Duchin,et al.  Case-reporting of acute hepatitis B and C among injection drug users , 2002, Journal of Urban Health.

[38]  M. Intorcia,et al.  Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town. , 2000, Journal of hepatology.

[39]  L. Magder,et al.  Hepatitis c in a community in Upper Egypt: risk factors for infection. , 2002, The American journal of tropical medicine and hygiene.

[40]  J. Desenclos,et al.  [Risk factors for hepatitis C virus transmission to Health Care Workers after occupational exposure: a European case-control study]. , 2005, Revue d'epidemiologie et de sante publique.

[41]  J. Duchin,et al.  Sharing of drug preparation equipment as a risk factor for hepatitis C. , 2001, American journal of public health.

[42]  P. Lopalco,et al.  Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy. , 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[43]  M. Abdel-hamid,et al.  Hepatitis C virus (HCV) infection in a community in the nile delta: Population description and HCV prevalence , 2000, Hepatology.

[44]  M. Sata,et al.  Hepatitis C virus seroconversion rate in a hyperendemic area of HCV in Japan: a prospective study. , 1997, Scandinavian journal of infectious diseases.

[45]  B. Bell,et al.  The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. , 2006, Journal of hepatology.

[46]  Chien-Jen Chen,et al.  Persistent hyperendemicity of hepatitis C virus infection in Taiwan: The important role of iatrogenic risk factors , 2001, Journal of medical virology.

[47]  H. Margolis,et al.  The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States , 2000, Hepatology.

[48]  D. Cardo,et al.  Transmission of HIV and hepatitis C virus from a nursing home patient to a health care worker. , 2003, American journal of infection control.

[49]  H. Margolis,et al.  Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. , 1990, JAMA.

[50]  D. Vlahov,et al.  Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. , 2003, American journal of epidemiology.

[51]  J. Hoofnagle,et al.  Viral hepatitis and liver disease , 1984 .

[52]  M. Alter,et al.  Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low‐risk population , 2006, Hepatology.

[53]  N. Terrault,et al.  Sexual activity as a risk factor for hepatitis C , 2002, Hepatology.

[54]  L. Gambotti,et al.  Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[55]  Chien-Jen Chen,et al.  Transmission of hepatitis C virus in Taiwan: Prevalence and risk factors based on a nationwide survey , 1999, Journal of medical virology.

[56]  J. Kaldor,et al.  Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. , 2003, International journal of epidemiology.

[57]  A. Valleron,et al.  Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe , 1999, Journal of viral hepatitis.

[58]  R. Weber,et al.  Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.